The proteinuria-lowering effects of dapagliflozin are associated with an initial decline in estimated glomerular filtration rate in patients with chronic kidney disease.
Maki MurakoshiTakashi KobayashiMasao KiharaSeiji UedaYusuke SuzukiTomohito GohdaPublished in: Nephrology (Carlton, Vic.) (2023)
The percent changes in UPCR were positively associated with the initial decline rate in eGFR in patients with CKD with a UPCR ≥0.5 g/gCr at baseline after 1 month of DAPA treatment.